KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) EPS (Basic): 2019-2024

Historic EPS (Basic) for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Dec 2024 value amounting to -$10.54.

  • Ginkgo Bioworks Holdings' EPS (Basic) fell 34.26% to -$1.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.19, marking a year-over-year increase of 52.02%. This contributed to the annual value of -$10.54 for FY2024, which is 42.62% up from last year.
  • As of FY2024, Ginkgo Bioworks Holdings' EPS (Basic) stood at -$10.54, which was up 42.62% from -$18.37 recorded in FY2023.
  • Over the past 5 years, Ginkgo Bioworks Holdings' EPS (Basic) peaked at -$0.10 during FY2020, and registered a low of -$50.15 during FY2022.
  • For the 3-year period, Ginkgo Bioworks Holdings' EPS (Basic) averaged around -$26.35, with its median value being -$18.37 (2023).
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' EPS (Basic) slumped by 3,614.81% in 2022, and later surged by 63.37% in 2023.
  • Yearly analysis of 5 years shows Ginkgo Bioworks Holdings' EPS (Basic) stood at -$0.10 in 2020, then plummeted by 1,250.00% to -$1.35 in 2021, then crashed by 3,614.81% to -$50.15 in 2022, then soared by 63.37% to -$18.37 in 2023, then soared by 42.62% to -$10.54 in 2024.